Identification |
Name: | Benzoicacid, 2-[[3-(3,4-dimethoxyphenyl)-1-oxo-2-propen-1-yl]amino]- |
Synonyms: | Anthranilic acid, N-(3,4-dimethoxycinnamoyl)-;N-(3,4-Dimethoxycinnamoyl)anthranilic acid;MK 341; |
CAS: | 53902-12-8 |
Molecular Formula: | C18H17NO5 |
Molecular Weight: | 327.33128 |
InChI: | InChI=1S/C18H17NO5/c1-23-15-9-7-12(11-16(15)24-2)8-10-17(20)19-14-6-4-3-5-13(14)18(21)22/h3-11H,1-2H3,(H,19,20)(H,21,22)/b10-8+ |
Molecular Structure: |
|
Properties |
Density: | 1.299 g/cm3 |
Refractive index: | 1.647 |
Water Solubility: | Soluble to 100 mM in DMSO |
Solubility: | 18 mg/mL in DMSO |
Appearance: | white with light yellow crystalline powder |
Biological Activity: | Antiallergic via inhibition of chemical mediator release from mast cells. Most recently shown to be an effective inhibitor of angiogenesis. Demonstrated to antagonize the effects of angiotensin II on human arteries, possibly by an interaction at the level of the AT 1 receptor. |
Usage: | An antiallergic drug. |
Safety Data |
Hazard Symbols |
Xn:Harmful
|
|
|